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Abstract
Cancer patients have high rates of persistent and disabling symptoms. Evidence suggests that 
social constraints (e.g., avoidance and criticism) negatively impact symptoms, but pathways 
linking these variables have yet to be identified. This study examined whether cancer-related 
loneliness (i.e., feeling socially disconnected related to having cancer) mediated the relationships 
between social constraints and symptoms (i.e., pain interference, fatigue, sleep disturbance, and 
cognitive complaints) in patients with various cancers (N=182). Patients (51% female, mean age = 
59) were recruited from the Indiana Cancer Registry and completed questionnaires assessing 
social constraints, cancer-related loneliness, and symptoms. Structural equation modeling was 
used to evaluate the hypothesized relationships among variables. The model demonstrated good 
fit. Consistent with our hypothesis, cancer-related loneliness mediated the relationships between 
social constraints and each symptom. Findings suggest that addressing cancer-related loneliness in 
symptom management interventions may mitigate the negative impact of social constraints on 
outcomes.
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About 40% of all men and women will be diagnosed with cancer at some point during their 
lifetime, with approximately 66% surviving 5 years post-diagnosis (SEER, 2015). Cancer 
patients experience significant symptoms resulting from cancer and its treatment. Across 
cancer types and stages, pain, fatigue, sleep disturbance, and cognitive complaints are 
among the most commonly reported symptoms (Kroenke et al., 2013; Savard et al., 2001; 
Schmidt et al., 2016; Servaes et al., 2002; van den Beuken-van Everdingen et al., 2007) and 
are associated with poorer quality of life (Kroenke et al., 2013). Fatigue is the most prevalent 
symptom in cancer patients, with the estimated prevalence ranging from 29–90% depending 
on the diagnostic criteria used (Cella et al., 2001; Wang et al., 2014). Sleep disturbance has 
also been reported by a large number of cancer patients, with rates of 30–50% being 
reported in recently diagnosed and treated patients (Savard & Morin, 2001). Additionally, 
53% of cancer patients across disease types, stages, and times since diagnosis report having 
pain, with more than one-third reporting moderate to severe pain (van den Beuken-van 
Everdingen et al., 2007). Furthermore, up to 35% of patients report cancer-related cognitive 
impairment following treatment (Janelsins et al., 2014). These symptoms are a major source 
of suffering and impairment for patients and often persist following cancer treatment 
(Harrington et al., 2010; Kroenke et al., 2013; Kroenke et al., 2010; Mao et al., 2007). 
Common treatments for these symptoms include medication (e.g., opioids, sleep aids), 
physical activity or physical rehabilitation, cognitive training (i.e., exercises to enhance 
memory), and psychological support (e.g., relaxation) (Bower, 2014; Glare et al., 2014; Von 
Ah et al., 2012). However, many cancer patients find existing treatments for their symptoms 
to be inadequate (Cella et al., 2001; Kroenke et al., 2013; Mao et al., 2007; Savard et al., 
2001; van den Beuken-van Everdingen et al., 2007).
Growing evidence suggests that cancer patients’ social environment plays a role in their 
symptom experience (Adams, Mosher, Cohee, et al., 2016; Wong & Lu, 2016; Yeung et al., 
2017). Because family and friends are an important source of practical and emotional 
support for symptom management, unsupportive or critical interactions may lead to 
increased symptoms. For example, if a patient’s partner minimizes their symptoms or 
criticizes their approach to symptom management, the patient may avoid discussing their 
symptoms in the future or fail to implement strategies to reduce them. Patients who alter 
their behavior or feel unable to disclose their cancer-related thoughts and feelings due to 
unsupportive interactions are experiencing social constraints (Lepore & Revenson, 2007). As 
expected, greater social constraints have been associated with greater symptoms (e.g., 
greater fatigue and sleep disturbance, poorer attentional functioning) in three samples of 
breast cancer patients (Adams, Mosher, Cohee, et al., 2016; Wong & Lu, 2016; Yeung et al., 
2017). In particular, greater social constraints were associated with greater avoidant coping, 
reduced self-efficacy for symptom management, and greater perceived stress, which in turn 
were associated with greater symptoms in this population (Adams, Mosher, Cohee, et al., 
2016; Yeung et al., 2017). These relationships have yet to be studied in patients with a 
broader range of cancer types.
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Additional psychological factors may be important in understanding the relationship 
between social constraints and cancer patients’ symptoms. For example, Wong and Lu 
(2016) found that Chinese American breast cancer patients’ level of acculturation moderated 
the relationship between social constraints and physical symptoms. Specifically, greater 
social constraints were only associated with greater symptoms among highly acculturated 
women. Disclosure is often more highly valued in American than Chinese culture 
(Fitzpatrick et al., 2006); thus, greater social constraints on disclosure were only associated 
with greater symptoms among women valuing or expecting disclosure. Relatedly, studies of 
patients with prostate and colorectal cancer found that socially constraining behaviors were 
more harmful to mental health for those reporting a greater need for emotional expression 
(Agustsdottir et al., 2010; Dagan et al., 2014). Taken together, findings suggest that 
relational dissatisfaction and social expectations are critical to understanding the impact of 
the social environment on health outcomes in cancer patients.
Loneliness is dissatisfaction with the quality of relationships stemming from unmet 
expectations for social involvement (Peplau & Perlman, 1982). Cancer-related loneliness, or 
loneliness attributed to the cancer experience, is associated with patients’ cancer-related 
social expectations (Adams et al., 2017). For example, patients may have unrealistic 
expectations for practical and emotional support following a cancer diagnosis that lead to 
greater cancer-related loneliness when these expectations are not met. In contrast to general 
feelings of loneliness, patients experiencing cancer-related loneliness are likely to feel very 
different from others due to their diagnosis and perceive cancer as something they must face 
alone emotionally. Like general loneliness, cancer-related loneliness is associated with 
greater depressive and anxiety symptoms and poorer mental and physical quality of life 
(Adams et al., 2017).
Cancer-related loneliness may be a key theory-based pathway linking social constraints and 
symptoms in cancer patients. First, social cognitive processing theory and existing literature 
suggest that greater social constraints lead to increased loneliness (Adams, Mosher, 
Abonour, et al., 2016; Lepore, 2001; Lepore & Revenson, 2007; Mosher et al., 2012). 
According to the social cognitive processing theory, social constraints on disclosure result in 
poorer psychological outcomes (e.g., loneliness) by preventing the cognitive processing of 
stress-related information with important others (Lepore, 2001; Lepore & Revenson, 2007). 
Second, consistent with loneliness theory, loneliness has been found to predict negative 
health outcomes in cancer patients, including greater symptoms (Hawkley & Cacioppo, 
2003). For example, loneliness was positively associated with fatigue and pain and 
negatively associated with sleep quality in recently diagnosed and long-term cancer 
survivors (Ferrell et al., 1995; Jaremka et al., 2013; Rijken et al., 1995). Furthermore, greater 
loneliness predicted increases in fatigue and pain over time in a study of breast cancer 
patients (Jaremka et al., 2014). Finally, loneliness has predicted cognitive decline in older 
adults (Wilson et al., 2007). Loneliness is theorized to impact health through multiple 
mechanisms, such as suboptimal health behaviors and heightened physiological reaction to 
stress (Hawkley & Cacioppo, 2003).
In the present study, we assessed cancer-related loneliness as a novel mediator of the 
relationships between social constraints and subjective reports of common and disabling 
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cancer symptoms (i.e., pain interference, fatigue, sleep disturbance, and cognitive 
complaints) in patients with various cancers. To our knowledge, this study is the first to 
examine links between social constraints and physical symptoms in patients with a broad 
range of cancer types. We hypothesized that cancer-related loneliness would mediate the 
positive relationships between social constraints and subjective reports of pain interference, 
fatigue, sleep disturbance, and cognitive complaints. Support for our hypothesis would 
suggest that symptom management interventions should consider targeting cancer-related 
loneliness.
Methods
Participants
Cancer patients were recruited from the Indiana Cancer Registry following institutional 
review board approval. Eligibility criteria included: (1) having been diagnosed with cancer 
in 2013 or 2014; (2) having received care for cancer at an Indiana University Health Hospital 
during 2013 or 2014; (3) being an English-speaking adult (≥18 years of age); and (4) having 
no evidence of serious cognitive impairment (based upon medical chart review and 
interactions with the patient during the informed consent process). Patients with brain cancer 
were excluded due to possible cognitive or personality changes related to their diagnosis. We 
enrolled patients who were diagnosed with cancer in 2013 or 2014 (i.e., within the past 2 
years of data collection) because we wanted to focus on individuals who would be more 
likely to identify with their cancer diagnosis. Eligibility status was determined by medical 
chart review and interactions during a telephone-based informed consent process.
Measures
Demographic and medical characteristics—The following characteristics were 
collected from participants’ medical records after informed consent: age, gender, cancer 
type, date of diagnosis, cancer treatments received (e.g., surgery, radiation, chemotherapy), 
and cancer stage (i.e., early vs. late/advanced). The following characteristics were collected 
via participant self-report: marital status, race/ethnicity, education level, and employment 
status.
Social constraints—A 5-item version of the Social Constraints Scale (Lepore et al., 
1996) was used to measure social constraints. The 5-item scale has been adapted for use in 
cancer patients in several studies (Danhauer et al., 2013; Halbert et al., 2010; Widows et al., 
2000), and this study assessed perceptions of socially constraining behaviors from “other 
people.” The measure uses a 5-point Likert-type scale with responses ranging from 1 
(almost never) to 5 (almost always). A sample item is “How often did you feel as though you 
had to keep your feelings about your cancer to yourself because they made other people 
uncomfortable?” A total score was calculated by summing the five items, after reverse-
scoring as necessary, with higher scores indicating greater social constraints. Evidence of the 
scale’s validity and internal consistency reliability has been reported in studies of cancer 
patients (Halbert et al., 2010; Widows et al., 2000). In the current study, internal consistency 
reliability was good (α=0.80).
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Cancer-related loneliness—The 7-item Cancer Loneliness Scale was used to assess 
cancer-related loneliness (i.e., loneliness attributed to the cancer experience) (Adams et al., 
2017). The measure uses a 5-point Likert-type scale with responses ranging from 1 (never) 
to 5 (always). A sample item is “How often does your cancer diagnosis make you feel 
isolated from others?” A total score was calculated by summing the seven items, with higher 
scores indicating greater cancer-related loneliness. Evidence of the scale’s excellent 
reliability and validity in the current sample has been published previously (Adams et al., 
2017; α=0.94).
PROMIS measures of health-related outcomes—Patient Reported Outcomes 
Measurement Information System (PROMIS) measures were used to assess pain 
interference, fatigue, sleep disturbance, and cognitive complaints. The PROMIS measures 
have undergone rigorous reliability and validity testing (Cella et al., 2010; Cella et al., 2007; 
Magasi et al., 2012).
Pain interference—The extent to which pain interfered with daily activities was assessed 
with the 4-item version of the Pain Interference measure (Amtmann et al., 2010). This 
measure uses a 5-point Likert-type scale with responses ranging from 1 (not at all) to 5 (very 
much). A sample item is “How much did pain interfere with your day to day activities?” A 
total score was calculated by summing the four items, with higher scores indicating greater 
subjective pain interference. Excellent reliability evidence is available for cancer patient 
samples (Teresi et al., 2016) and both reliability and validity evidence is available for 
general population samples (Amtmann et al., 2010). In the current study, internal 
consistency reliability was excellent (α=0.97).
Fatigue—Subjective fatigue severity was assessed with the 4-item version of the PROMIS 
Fatigue measure (Lai et al., 2011). This measure uses a 5-point Likert-type scale with 
responses ranging from 1 (not at all) to 5 (very much). A sample item is “In the past 7 days, 
how fatigued were you on average?” A total score was calculated by summing the four 
items, with higher scores indicating greater subjective fatigue. Adequate reliability and 
validity evidence has been obtained for PROMIS fatigue items in cancer patient samples 
(Barsevick et al., 2013; Lai et al., 2006; Wagner et al., 2015). In the current study, internal 
consistency reliability was excellent (α=0.95).
Sleep disturbance—Subjective sleep disturbance was assessed with the 4-item version of 
the PROMIS Sleep Disturbance measure (Buysse et al., 2010; Yu et al., 2012). This measure 
uses two 5-point Likert-type scales. For the first 3 items (e.g., “In the past 7 days, I had a 
problem with my sleep”), responses range from 1 (not at all) to 5 (very much) and for the 
fourth item (i.e., “My sleep quality is…”) responses range from 1 (very poor) to 5 (very 
good). A total score was calculated by summing the four items, after reverse-scoring as 
needed, with higher scores indicating greater subjective sleep disturbance. Excellent 
reliability and validity evidence is available for cancer patient samples (Jensen et al., 2016). 
In the current study, internal consistency reliability was excellent (α=0.90).
Cognitive complaints—Cognitive complaints were assessed with the 4-item PROMIS 
Applied Cognition—General Concerns measure (Cella et al., 2012). This measure uses a 5-
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point Likert-type scale with responses ranging from 1 (never) to 5 (very often- several times 
a day). A sample item is “I have had to work harder than usual to keep track of what I was 
doing.” A total score was calculated by summing the four items, with higher scores 
indicating more cognitive complaints. Reliability and validity evidence has been published 
(Cella et al., 2012). In the current sample, internal consistency reliability was excellent 
(α=0.93).
Procedure
Potential participants were identified through the Indiana Cancer Registry, a list of every 
cancer case in the state of Indiana. A waiver of HIPAA authorization was obtained to review 
the medical records of patients on the list to confirm their eligibility. To ensure 
representation of demographic subgroups, we used purposive sampling based on gender and 
race. Patients were randomly selected from the list within racial and gender categories. An 
introductory letter and information sheets describing the study were mailed to each 
potentially eligible person. In the letter, patients were invited to call for more details or to 
opt out. A research team member called all prospective participants who did not opt out to 
describe the study and interested patients consented to participate by phone. Consenting 
patients were mailed a survey to complete at home and a pre-paid, addressed envelope for 
returning the survey. Reminder calls were made as necessary. Participants who returned their 
survey received a $25 gift card.
Statistical Analyses
First, we examined the assumptions of normality and linearity. According to Kline (2011), 
the values for each study variable were appropriate. Second, because we had very little 
missing data (i.e., most variables were missing 0.5% of their values), when an individual 
item was missing from a scale, we imputed the value of the strongest correlated item in that 
scale. However, a total of 4 cases were excluded from the analyses because all of the items 
in a particular scale were missing. Next, descriptive statistics and zero-order correlations 
were computed to characterize the sample.
The hypothesized path model was tested using structural equation modeling with 
bootstrapping and a robust maximum likelihood estimator in Mplus statistical software. 
Endogenous variables (i.e., mediator and dependent variables) included cancer-related 
loneliness, pain interference, fatigue, sleep disturbance, and cognitive complaints. The error 
variances of the endogenous variables were allowed to correlate. The exogenous variable 
(i.e., independent variable) was social constraints. To evaluate the models’ fit, we examined 
the goodness-of-fit χ2 statistics, the root mean square error of approximation (RMSEA) 
statistics, the comparative fit indices (CFI), and the standardized root mean square residual 
(SRMR) statistics. As suggested by Hu and Bentler (1999), adequate model fit was defined 
as follows: (1) a non-significant χ2 statistic indicating no difference between the modeled 
and observed patterns of relationships; (2) RMSEA<0.06; (3) CFI>0.95; and (4) 
SRMR<0.08. The indirect effects were assessed by computing bias-corrected bootstrapped 
confidence intervals. The primary analysis was conducted without covariates to avoid 
overfitting the model. However, an adjusted model was also run to test whether the 
hypothesized indirect effects would remain after controlling for demographic and medical 
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factors (i.e., age, time since diagnosis, marital status, education level) that were significantly 
associated with the symptom outcomes. Gender was not associated with any outcomes and 
therefore was not included as a covariate.
Results
Sample Characteristics
A total of 380 patients randomly selected within race and gender categories were deemed 
eligible based on medical chart review and were sent introductory letters. Of the 380 patients 
sent introductory letters, 36 (9%) were found to be ineligible. Of the remaining 344 patients, 
215 (63%) consented to participate, 47 (14%) declined participation, and 82 (24%) could not 
be reached via phone. Of the 215 consenters, 186 (87%) returned their surveys. As discussed 
previously, four cases were excluded from the analyses because all of the items in a 
particular scale were missing. Demographic and medical characteristics of participants 
included in the final analyses (N=182) are shown in Table 1. Descriptive statistics and zero-
order correlations for all study variables are shown in Table 2. Patients reported experiencing 
low levels of social constraints on average, consistent with prior research with cancer 
patients (Hoyt, 2009; Mosher et al., 2012). In addition, the average patient reported “rarely” 
feeling loneliness related to their cancer diagnosis. On average, patients reported 
experiencing “a little bit” of pain interference, fatigue, and sleep disturbance, and “rarely” 
having cognitive difficulties. Patients’ levels of pain and fatigue were comparable to those of 
a representative sample of American cancer patients (see www.nihpromis.com). Patients’ 
average level of sleep disturbance was comparable to levels reported in another study of 
cancer patients (Stachler et al., 2014).
All correlations between variables were in expected directions. Social constraints and 
cancer-related loneliness were strongly correlated (r = 0.80), and both were moderately 
correlated with symptoms. Among the symptoms, pain interference, fatigue, and sleep 
disturbance had the highest correlations with one another (rs = 0.60–0.70), whereas 
correlations between cognitive complaints and other symptoms were moderate.
Main Findings
Figure 1 shows the results for the hypothesized mediation model. The model showed good 
fit as determined by the χ2 statistic (χ2 = 9.96, df = 4, bootstrap p = 0.229) and goodness of 
fit indices (i.e., RMSEA= 0.09, CFI = 0.99, and SRMR= 0.03). As hypothesized, cancer-
related loneliness mediated the relationships between social constraints and pain interference 
(z = 0.40, p < 0.0001, CI: 0.31, 0.49), fatigue (z = 0.35, p < 0.0001, CI: 0.28, 0.43), sleep 
disturbance (z = 0.41, p < 0.0001, CI: 0.34, 0.48), and cognitive complaints (z = 0.44, p < 
0.0001, CI: 0.38, 0.52). Specifically, greater social constraints on cancer-related disclosure 
were associated with greater cancer-related loneliness (β = 0.80, p < 0.0001), which in turn 
was associated with greater pain interference (β = 0.50, p < 0.0001), fatigue (β = 0.44, p < 
0.0001), sleep disturbance (β = 0.51, p < 0.0001), and cognitive complaints (β = 0.55 p < 
0.0001). All symptom outcomes were also positively associated with each other. The 
associations between pain interference and two other symptoms (i.e., fatigue, cognitive 
complaints) were weak, whereas associations among all other symptom outcomes were 
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moderate. Results of the adjusted model also revealed good fit and significant indirect 
effects for all outcome variables (data not shown).
Discussion
In this study, cancer-related loneliness was identified as a pathway underlying the 
relationships between social constraints and subjective symptoms in cancer patients. The 
findings extend our understanding of mechanisms through which the social environment 
impacts physical health outcomes by identifying a novel mediating variable, cancer-related 
loneliness. The findings also support hypotheses derived from social cognitive processing 
theory and loneliness theory linking social constraints to loneliness and loneliness to poor 
health outcomes (Hawkley & Cacioppo, 2003; Lepore, 2001; Lepore & Revenson, 2007). As 
patients experience constraints on cancer-related disclosure, their sense of belongingness in 
relationships and level of disclosure may decrease, which, in turn, may amplify loneliness 
attributed to cancer. Loneliness may result in poor health behaviors and stronger 
physiological responses to stress that, in turn, may heighten symptoms such as pain, fatigue, 
and cognitive difficulties (Hawkley & Cacioppo, 2003). Three prior studies linked social 
constraints to symptoms in breast cancer survivors (Adams, Mosher, Cohee, et al., 2016; 
Wong & Lu, 2016; Yeung et al., 2017), whereas this study is the first to examine links 
between social constraints and subjective physical symptoms in patients with various 
cancers.
Results of the current study have implications for future research and clinical practice. To 
date, existing symptom management interventions, such as physical activity or medications, 
have been insufficient, as many cancer patients experience persistent and disabling 
symptoms following their treatment (Kroenke et al., 2013; Kroenke et al., 2010; Mao et al., 
2007). As evidence converges regarding the negative impact of unsupportive social 
interactions on symptom outcomes, it is important to identify modifiable treatment targets. A 
focus on social factors is likely to impact symptoms both directly (e.g., psychosocial factors 
impact pain sensitivity; Gatchel et al., 2007) and indirectly (e.g., through engagement in 
treatment) and may be a key missing component in interventions. Cancer-related loneliness 
is a practical treatment target, as it can be modified in individual or group sessions (Masi et 
al., 2010) that do not require the involvement of patients’ family or friends who may be 
unwilling or unable to participate. Patients’ cancer-related loneliness is strongly related to 
their social expectations (Adams et al., 2017), which may be modifiable through individual 
therapy, such as cognitive-behavioral therapy. Indeed, a meta-analysis found that loneliness-
reduction interventions are most effective at reducing loneliness if they target maladaptive 
social cognitions (Masi et al., 2010). These interventions have rarely focused on cancer 
populations, but those that do show promise (Cleary & Stanton, 2015; Fukui et al., 2003; 
Samarel et al., 2002). Research is needed to determine whether interventions targeting 
cancer patients’ loneliness may mitigate the negative impact of social constraints on their 
subjective symptoms. These loneliness interventions should be tailored to address cancer-
related social conditions and social expectations.
Limitations of this study and additional directions for future research should be noted. First, 
although our consent and survey return rates were comparable to similar research (Eakin & 
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Strycker, 2001), patients who participated may have differed from those who chose not to 
participate or could not be contacted. Second, cancer patients were recruited from a single 
geographic region in the Midwestern United States. Findings warrant replication in a sample 
that is fully representative of the general population of cancer patients. Third, the cross-
sectional design precluded an examination of directionality. For example, although we 
hypothesized that greater social constraints would lead to greater cancer-related loneliness, it 
is possible that loneliness contributed to social constraints. Specifically, lonely patients may 
invite more negative interactions than those who are not lonely (Cacioppo & Hawkley, 
2009). Additionally, greater subjective symptoms, which interfere with social interactions 
(e.g., pain or fatigue keeping the patient at home), might lead to greater feelings of 
loneliness. However, prior research found that loneliness predicted breast and colorectal 
cancer patients’ subjective symptoms over time (Jaremka et al., 2014). Further research is 
needed to compare the effects of general vs. cancer-related loneliness on these outcomes. 
Longitudinal research is also needed to further investigate processes through which social 
constraints impact cancer patients’ symptoms. Finally, there are no recommended clinical 
cut-offs for social constraints or cancer-related loneliness; establishing clinical cut-offs could 
guide efforts to assess for social processes warranting intervention.
In summary, many cancer patients endorse significant symptoms that have not been 
addressed by current intervention strategies (Kroenke et al., 2013; Kroenke et al., 2010; Mao 
et al., 2007). Evidence that the social environment affects symptom management should be 
considered if we are to improve intervention outcomes. Cancer-related loneliness reflects 
patients’ attributions regarding their social environment and is related to symptom 
management and other health outcomes (Adams et al., 2017). Cancer-related loneliness is a 
practical treatment target that could be readily incorporated into symptom management 
interventions for cancer patients. The development of symptom management interventions 
that consider loneliness and other social contributors to health may significantly improve 
cancer patients’ quality of life.
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Figure 1. Relationships between Social Constraints, Cancer-related Loneliness, and Patient 
Symptoms
Note. All pathways and covariances are significant with p < 0.05. χ2 (4, N = 182) = 9.96, 
Bootstrap p = 0.229, RMSEA = 0.090 (90% CI: 0.017, 0.163), SRMR = 0.034, CFI = 0.990. 
The arrows above the boxes are disturbance terms, denoting the amount of unexplained 
variance. For example, 0.36 above cancer-related loneliness indicates that 36% of the 
variance in this variable is unexplained by the current model.
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Table 1
Sample Characteristics (N = 182)
Characteristic N (%) M (SD) Range
Average age 59.3 (12.7) 21.0–87.0
Female gender 93 (51.1)
Race/ethnicity
  White 137 (75.2)
  Black or African American 38 (20.9)
  Other race 7 (3.8)
Marital status
  Married/living with partner 123 (67.6)
  Divorced, separated, or widowed 38 (20.9)
  Never married 21 (11.5)
Education level
  Elementary or some high school 13 (7.1)
  High school graduate 61 (33.5)
  Some college or technical school 56 (30.8)
  College graduate 52 (28.6)
Employment status
  Employed full or part-time 77 (42.3)
  Retired 62 (34.1)
  Unemployed due to disability 29 (15.9)
  Other 13 (7.1)
  Missing 1 (0.01)
Cancer types
  Breast 28 (15.4)
  Prostate 20 (11.0)
  Skin 13 (7.1)
  Uterine 13 (7.1)
  Kidney 12 (6.6)
  Colon 11 (6.0)
  Lung 10 (5.4)
  Other types (31 total other types) 74 (40.7)
  Unknown primary 1 (0.01)
Cancer stage
  Early stage 114 (62.6)
  Late stage 45 (24.7)
  N/A staging system 9 (4.9)
  Missing 14 (7.7)
Months since diagnosis 16.7 (3.2) 1.0–24.3
Cancer treatments received
  Surgery 152 (83.5)
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Characteristic N (%) M (SD) Range
  Chemotherapy 70 (38.5)
  Radiation 58 (31.9)
  Hormone therapy 35 (19.2)
  Immunotherapy 15 (8.2)
  Stem cell transplant 4 (2.2)
  Other 2 (1.1)
Note. M = Mean. SD = standard deviation. N/A = not applicable.
J Behav Med. Author manuscript; available in PMC 2019 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Adams et al. Page 17
Ta
bl
e 
2
Ze
ro
-o
rd
er
 C
or
re
la
tio
ns
 a
nd
 D
es
cr
ip
tiv
e 
St
at
ist
ic
s f
or
 S
tu
dy
 M
ea
su
re
s
M
ea
su
re
So
ci
al
C
on
st
ra
in
ts
C
an
ce
r-
re
la
te
d
Lo
ne
lin
es
s
Pa
in
In
te
rf
er
en
ce
Fa
tig
ue
Sl
ee
p
D
ist
ur
ba
nc
es
C
og
ni
tiv
e
C
om
pl
ai
nt
s
So
ci
al
 C
on
str
ai
nt
s
—
0.
80
0.
48
0.
46
0.
49
0.
53
Ca
nc
er
-
re
la
te
d 
Lo
ne
lin
es
s
0.
80
—
0.
50
0.
44
0.
51
0.
55
Pa
in
 In
te
rfe
re
nc
e
0.
48
0.
50
—
0.
70
0.
60
0.
48
Fa
tig
ue
0.
46
0.
44
0.
70
—
0.
67
0.
53
Sl
ee
p 
di
stu
rb
an
ce
0.
49
0.
51
0.
60
0.
67
—
0.
47
Co
gn
iti
v
e 
Co
m
pl
ai
nt
s
0.
53
0.
55
0.
48
0.
53
0.
47
—
M
ea
n
9.
40
13
.6
0
7.
80
9.
70
9.
90
8.
50
St
an
da
rd
 D
ev
ia
tio
n
4.
20
6.
70
4.
50
4.
00
3.
90
3.
90
R
an
ge
5.
00
–2
5.
00
7.
00
–3
5.
00
4.
00
–2
0.
00
4.
00
–2
0.
00
4.
00
–2
0.
00
4.
00
–2
0.
00
N
ot
e. 
A
ll 
ps
 <
 0
.0
01
.
J Behav Med. Author manuscript; available in PMC 2019 April 01.
